Literature DB >> 4564679

In vitro response of human lymphocytes to Mycoplasma pneumoniae.

G W Fernald.   

Abstract

In vitro culture and stimulation of human peripheral lymphocytes were employed to investigate the role of cellular immunity in Mycoplasma pneumoniae disease. Subjects with documented natural infections served as donors. The lymphocyte response to whole M. pneumoniae organisms was determined as incorporation of tritiated thymidine in a semimicro culture system. The range of cellular reactivity stimulated by specific antigen was within the range stimulated by phytohemagglutinin. The difference between responses of subjects with documented infection and serologically negative controls was highly significant. Specific reactivity of peripheral lymphocytes correlated closely with the presence of serum growth-inhibiting antibodies, and both persisted for several years following infection. Serum complement-fixing titers correlated well with lymphocyte stimulability during the first year but antibody, as measured by this technique, tended to disappear in later convalescence. In light of previous studies, which revealed a lack of correlation between humoral antibodies and resistance to reinfection, these results suggest that immunity to M. pneumoniae infection is mediated by circulating small lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4564679      PMCID: PMC422406          DOI: 10.1128/iai.5.4.552-558.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.

Authors:  G W Fernald; W A Clyde
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

2.  Control of acute mycoplasmal and viral respiratory tract disease.

Authors:  R M Chanock
Journal:  Science       Date:  1970-07-17       Impact factor: 47.728

3.  Fatal Mycoplasma pneumoniae infection with isolation of organisms from lung.

Authors:  J C Maisel; L H Babbitt; T J John
Journal:  JAMA       Date:  1967-10-23       Impact factor: 56.272

Review 4.  Mycoplasma infections in childhood.

Authors:  W A Clyde; F W Denny
Journal:  Pediatrics       Date:  1967-10       Impact factor: 7.124

5.  Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis.

Authors:  W M Newberry; J W Chandler; T D Chin; C H Kirkpatrick
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

6.  Ecology of Mycoplasma pneumoniae infections in marine recruits at Parris Island, South Carolina.

Authors:  P Steinberg; R J White; S L Fuld; R R Gutekunst; R M Chanock; L B Senterfit
Journal:  Am J Epidemiol       Date:  1969-01       Impact factor: 4.897

7.  In vitro studies of the response of hamster lymphocytes to phytohemagglutinin and antigenic stimulation.

Authors:  G W Fernald; R S Metzgar
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

8.  Antibodies in bronchial secretions following natural infection with Mycoplasma pneumoniae.

Authors:  G Biberfeld; G Sterner
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

9.  Factors influencing growth inhibition of Mycoplasma pneumoniae by immune sera.

Authors:  G W Fernald; W A Clyde; F W Denny
Journal:  Proc Soc Exp Biol Med       Date:  1967-10

10.  Immunopathology of experimental Mycoplasma pneumoniae disease.

Authors:  W A Clyde
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

View more
  13 in total

1.  Effect of A. laidlawii on murine and human lymphocyte cultures.

Authors:  H Kirchner; H Brunner; H Rühl
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

2.  Effect of Mycoplasma pheumoniae infection on cell-mediated immunity.

Authors:  G Biberfeld; G Sterner
Journal:  Infection       Date:  1976       Impact factor: 3.553

3.  Cell-mediated immune response following Mycoplasma pneumoniae infection in man. II. Leucocyte migration inhibition.

Authors:  G Biberfeld
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

4.  Cell-mediated immune response following Mycoplasma pneumoniae infection in man. I. Lymphocyte stimulation.

Authors:  G Biberfeld; P Biberfeld; G Sterner
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

5.  Mitogenicity of Mycoplasma fermentans for human lymphocytes.

Authors:  E Nilsson
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

6.  Ciliated respiratory epithelial monolayers: new model for Mycoplasma pneumoniae infection.

Authors:  M G Gabridge; H Gunderson; S L Schaeffer; Y D Barden-Stahl
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

7.  Lymphocyte transformation studies in Mycoplasma pneumoniae infections.

Authors:  H H Mogensen; V Andersen; K Lind
Journal:  Infection       Date:  1976       Impact factor: 3.553

Review 8.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Epidemic caprine keratoconjunctivitis: experimentally induced disease with a pure culture of Mycoplasma conjunctivae.

Authors:  S L Trotter; R M Franklin; E J Baas; M F Barile
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

10.  Delayed hypersensitivity to nonviable Mycoplasma pulmonis in mice is enhanced by dextran sulfate.

Authors:  M Kishima; C Kuniyasu; M Nakagawa
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.